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Background: Maternal smoking is a risk factor for pediatric lung disease, including asthma. Animal models suggest
that maternal smoking causes defective alveolarization in the offspring. Retinoic acid signaling modulates both lung
development and postnatal immune function. Thus, abnormalities in this pathway could mediate maternal smoking
effects. We tested whether maternal smoking disrupts retinoic acid pathway expression and functioning in a murine
model.
Methods: Female C57Bl/6 mice with/without mainstream cigarette smoke exposure (3 research cigarettes a day,
5 days a week) were mated to nonsmoking males. Cigarette smoke exposure continued throughout the pregnancy
and after parturition. Lung tissue from the offspring was examined by mean linear intercept analysis and by
quantitative PCR. Cell culture experiments using the type II cell-like cell line, A549, tested whether lipid-soluble
cigarette smoke components affected binding and activation of retinoic acid response elements in vitro.
Results: Compared to tobacco-naïve mice, juvenile mice with tobacco toxin exposure had significantly (P< 0.05)
increased mean linear intercepts, consistent with an alveolarization defect. Tobacco toxin exposure significantly
(P< 0.05) decreased mRNA and protein expression of retinoic acid signaling pathway elements, including retinoic
acid receptor alpha and retinoic acid receptor beta, with the greatest number of changes observed between
postnatal days 3–5. Lipid-soluble cigarette smoke components significantly (P< 0.05) decreased retinoic
acid-induced binding and activation of the retinoic acid receptor response element in A549 cells.
Conclusions: A murine model of maternal cigarette smoking causes abnormal alveolarization in association with
altered retinoic acid pathway element expression in the offspring. An in vitro cell culture model shows that
lipid-soluble components of cigarette smoke decrease retinoic acid response element activation. It is feasible that
disruption of retinoic acid signaling contributes to the pediatric lung dysfunction caused by maternal smoking.
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Maternal smoking is an important risk factor for pediatric
lung dysfunction, including asthma [1-6]. Children of
mothers who smoke cigarettes have increased risk of
lower respiratory tract infections and wheezing during
their first year, and higher incidence of persistent wheeze
and doctor-diagnosed asthma [4,5,7,8]. Additionally, ma-
ternal smoking is associated with increased frequency of
asthma exacerbations among children [5,9]. Nonsmoking* Correspondence: khaley@rics.bwh.harvard.edu
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reproduction in any medium, provided the oradults who report a history of childhood tobacco smoke
exposure have lower baseline FEV-1 and a more rapid de-
cline in pulmonary function tests after starting cigarette
smoking [10,11]. Therefore, environmental insults such as
tobacco toxin exposure during lung development may
have a life-long impact on lung growth and function. The
possibility of an early life insult leading to increased vul-
nerability to postnatal disease has been termed the “fetal
origins” or “developmental origins” hypothesis [12,13].
Given that approximately 20% women between ages 18 –
44 years report current smoking, and current maternal
smoking is reported in approximately 1 in 7 pregnancies in
the United States [14,15], effective approaches to theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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function will combine anti-smoking education with
mechanistically-based therapies. Currently, however, the
mechanisms of lung injury in children exposed to maternal
smoking have not been fully clarified.
One possible pathway that could mediate some of the
lung abnormalities caused by maternal smoking is the
retinoic acid (RA) signaling pathway. RA is produced by
vitamin A metabolism by successive oxidative reactions
from dietary precursors including retinyl esters and car-
otenoids such as beta carotene [16,17]. The retinoids are
well-described as critical mediators of alveolar develop-
ment [18-22] and are also involved in the maintenance
of normal postnatal lung epithelium and immune
responses [18,23-25]. Cigarette smoking causes abnormal-
ities in retinol levels in rodents [26]. In humans, cigarette
smokers have decreased beta carotene compared to non-
smokers [27,28]; this decrease exceeds that explained by
differences in dietary intake [29]. The data regarding
changes in serum retinol levels in cigarette smokers are
less consistent. Several studies comparing serum retinol
levels in smokers versus nonsmokers have not demon-
strated statistically significant differences [30-33]. In con-
trast, a large study (over 600 subjects in each group) did
demonstrate lower mean serum retinol levels in current
smokers compared to former smokers [28].
We hypothesized that prenatal exposure to tobacco
toxins would decrease elements of the retinoic acid sig-
naling pathway in the immature lung. We tested this hy-
pothesis by examining lung tissue from mice with
exposure to cigarette smoke byproducts during develop-
ment and by examining an in vitro cell culture model to
determine if lipid-soluble cigarette smoke extract caused
abnormal RA receptor activation. Our findings indicate
that maternal cigarette smoke decreases expression of
several retinoic acid pathway components in the lungs
of the offspring, and that these effects persist well into
the postnatal period.
Methods
All of the animal protocols used in this study were
reviewed and approved in advance by the Harvard Med-
ical School institutional review board (IACUC).
Animal model
Study animals were housed in pathogen-free conditions,
with ad libitum food and water in microisolator cages.
Beginning at 10 weeks of age, female C57Bl/6 mice
(Charles River Laboratories, Waltham, MA) received
daily exposure to the smoke of 3 3R4F research cigar-
ettes (University of Kentucky), 5 times per week. Control
mice were exposed to filtered air using a dedicated
HEPA Tecniplast SLIMLine™ filtration system (Tecni-
plast, Westchester, PA). The cigarette smoke wasdelivered using a custom-built apparatus that provides
mainstream cigarette smoke exposure to the nose and
face of the mouse. The exposures were initiated grad-
ually, with smoke from 1 cigarette on the first day, 2 on
the second day, and 3 daily thereafter. The cigarette
smoke was delivered from sequential cigarettes during
one session lasting approximately 30 minutes per mouse.
The mice were continuously observed during the smoke
exposure, and promptly removed from the smoke expos-
ure chamber if any signs of distress were noted. After a
2-wk acclimation period, the females were mated to
nonsmoking males. Cigarette smoke exposures were
continued throughout pregnancy and after parturition.
The pups were randomly allocated among the experi-
mental groups. Tissue samples from the pups were col-
lected after euthanasia following recommended IACUC
prototols: carbon dioxide followed by excision of vital
organs. At time points up to P10, tracheal transaction/
decapitation was also performed after establishing car-
bon dioxide-induced narcosis by approximately 5 min-
utes of carbon dioxide exposure. The presence of
narcosis was verified by observing the absence of breath-
ing movements and the lack of response to tail pinch.
Lung tissue samples from the offspring were collected
on the day of birth (P0), postnatal day 3 (P3), P5, P7,
P10, and P14 for RNA and protein analyses. These time
points were chosen to sample the early neonatal period
through the time of rapid alveolarization. Due to size
constraints, whole lung samples were collected from P0
mice. Lung tissue samples from subsequent time points
were obtained from areas located at least 3 – 5 mm dis-
tal to the lung hilum. This sampling strategy permitted
examination of the distal lung areas, where alveolariza-
tion occurs. Both RNA and protein analyses included a
total of at least 4 pups from the litters of at least 2
females. Additional P14 mice with/without tobacco toxin
exposure were analyzed for changes in lung histology, as
outlined below in “Histological Analyses”. Placenta and
serum samples were harvested from additional pregnant
females with (N= 8) and without (N= 8) cigarette smoke
exposure at embryonic day e15.5 and e17.5.
The total particulates from the cigarette smoking
chambers were measured by connecting the smoke
chamber to a dry gas meter (catalog # GNM G1.6 T,
AEM, Romania) in-line with an air monitoring filter
holder. A 12 mm diameter borosilicate air monitoring
filter (catalog # TX40HI20WW, PallflexW Emfab™ filter,
Pall Life Sciences) was weighed, and placed into the fil-
ter holder, and the smoking machine activated with a
3R4F cigarette After 8 minutes of exposure, the paper
was weighed, and the total particulates calculated as fol-
lows: Total particulates = change in filter weight/ change
in dry gas volume. Measurement was repeated, and an
average total particulate measure calculated.
Table 1 Catalog numbers for qPCR primer/probe sets
Primer/Probe Set Catalog Number
Retinaldehyde dehydrogenase-1 Mm 00657317_m1
Retinaldehyde dehydrogenase-2 Mm00501306_m1
RA receptor alpha Mm 00436264 –m1
RA receptor beta Mm 01319680_m1
RA receptor gamma Mm 00441083_m1
Retinoid X receptor alpha Mm 01332431_m1
Retinoid X receptor beta Mm 00441193_m1
Retinoid X receptor gamma Mm 00436410_m1
Nuclear receptor subfamily 2, group F, member 2 Mm00772789_m1
Cytochrome P450 26b1 Mm00558507_m1
Vascular Endothelial Growth Factor-α Mm00437304_m1
Transforming Growth Factor-beta Mm03024053_m1
Surfactant apoprotein A Mm00499170_m1
Surfactant apoprotein B Mm00455681_m1
18 S (eukaryotic) Hs 99999901_s1
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Changes in airspace architecture were estimated by cal-
culating the mean linear intercept, which is an estimate
of the average difference between gas exchange surfaces
[34]. For these studies, lung tissue from P14 mice with
(n = 16) and without (n = 12) exposure to tobacco toxins
during development was inflated to 25 cm water pres-
sure, and fixed in 10% formalin (Thermo Fisher Scien-
tific Inc., Waltham, MA). The lungs were routinely
processed and infiltrated with paraffin, sectioned in the
mid-sagittal line prior to embedding in paraffin with the
midsagittal line oriented to the block face, routinely sec-
tioned into 5-microns thick sections, and stained with
hematoxylin and eosin (Sigma -AldrichW, St. Louis,
MO). Using random numbers to determine sampling
areas, five independent, uniform random 20X fields that
were located within 100 microns of the pleural surface
were digitally photographed using a Leica DMLB micro-
scope interfaced with a Leica DFC480 digital camera
(Leica Microsystems, Inc., Buffalo Grove, IL) by a
blinded experienced reader (KH). Vascular structures
and bronchi were identified by the typical appearance of
the endothelial and epithelial cells, respectively, and
digitally isolated from the areas to be measured, so that
only distal airspaces were analyzed. The images were
analyzed using Image J image analysis software (http://
rsb.info.nih.gov/ij/) to determine the mean linear inter-
cept as a measure of the average distance between gas
exchange surfaces, as outlined in the American Thoracic
Society/European Respiratory Society Standards for
Quantitative Assessment of Lung Structure [34].
Cotinine measurements
Crude placenta tissue extracts were prepared from 100–
150 mg mouse placenta tissue by homogenization in
200 μl homogenization buffer (50 mM Tris–HCl,
150 mM KCl, 2 mM EDTA, pH. 7.5). Homogenates were
centrifuged at 1000 X G for 15 minutes at 4°C. Cotinine
was detected using 10 μl placenta extract or blood
(diluted 1:2 in tissue homogenization buffer) with the
Cotinine Direct ELISA kit (Calbiotech, Spring Valley,
CA) according to manufacturer’s directions. Standard
curves were prepared from serial dilutions of cotinine
from 100 ng/ml to 1 ng/ml. Cotinine concentrations in
placenta extracts and blood were calculated from a 4-
parameter Logistic/Log analysis of the standard curves
(SigmaPlot 6.0) as previously described [35].
Real time (quantitative) PCR
RNA extraction was performed using TriReagent (Mo-
lecular Research Center, Inc.), according to manufacturer’s
instructions, and was followed by DNase I (Invitrogen/Life
Technologies, Grand Island, NY) treatment and reverse
transcription to cDNA (RetroscriptW, Ambion/LifeTechnologies) as previously described [36]. Real time
polymerase chain reaction (qPCR) using validated Taqman
primers and probes (Applied Biosystems/Life Technolo-
gies) was performed as previously described [36]. The
catalog numbers for the primer/probe sets are given in
Table 1, below. All of the primers except for 18 S spanned
an intron.
Protein extraction and western blotting analyses
Lung tissue harvested as outlined above from mice at
ages postnatal day 3, 5, and 7 was snap frozen for pro-
tein extraction. The used of distal lung tissue enriched
the samples for areas of developing alveoli. Total protein
was extracted using Bio-Rad Protein Extraction kit (Bio-
Rad Life Science Research, Hercules, CA) followed by
Bio-Rad 2D cleanup kit (Bio-Rad), following manufac-
turer’s instructions, and then quantitated using bicincho-
ninic acid assay (Sigma). The protein samples were then
analyzed by Western blotting, which was performed with
modified method as previously described [37]. Briefly,
after blocking for 1 h at room temperature with 5% non-
fat dry milk in TBST buffer, the membranes were incu-
bated with primary antibodies overnight at 4°C. Rabbit
anti-RXRalpha (sc553, used at 200 ng/ml), RARalpha
(sc551, used at 200 ng/ml), RARbeta (sc552, used at
200 ng/ml) and mouse anti-RARgamma (sc7387, used at
200 ng/ml) antibodies were obtained from Santa Cruz
Biotechnology, Inc., Santa Cruz, CA. Mouse anti-beta
actin (A2228, clone AC-74, used at 400 ng/ml) was pur-
chased from Sigma. After brief washing, the membranes
were incubated with horseradish peroxidase-conjugated
secondary antibodies for 15 min at room temperature,
extensively washed in TBST buffer, and then bands of
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chemiluminescence (Amersham ECL Plus™ Western De-
tection Kit, GE Healthcare Biosciences, Pittsburgh, PA).
The blots were visualized by ChemiDoc XRS+ System
(Bio-Rad), and densitometry was performed to compare
the relative intensities of the bands.
Cell culture and transient transfection
A549 cells (ATCC) were maintained in Dulbelcco’s
Modified Eagle Medium with 10% fetal bovine serum
(Invitrogen Life Sciences), 1% L-glutamine (GIBCO/Invi-
trogen Life Sciences), and 2% penicillin/streptomycin
(10,000 units penicillin/ml and 10 mg streptomycin/ml,
Sigma). Transfection experiments were performed using
standard protocols [38]. The transfection reagent was
Fugene 6 (Roche Applied Science, Indianapolis, IN),
used following the manufacturer’s instructions, with a
3:1 ratio of Fugene to total plasmid DNA. The plasmids
used were a luciferase reporter plasmid containing RA
response element (Panomics/Affymetrix Inc., Santa
Clara, CA), empty vector (negative control plasmid,
Panomics), pGL2 (Promega, Madison, WI; positive con-
trol plasmid, generous gift of M. Layne, Ph.D.), and a
beta-galactosidase expression plasmid (used for normal-
izing luciferase activity, generous gift of M. Layne). Ap-
proximately 1.5 hours after transfection, cultures were
treated with cigarette smoke condensate (CSC, Murty
Pharmaceuticals Incorporated, Lexington, KY) at con-
centrations of 0.25% and 0.50% total volume and 1 μM
all-trans retinoic acid (Sigma). Cultures were incubated
overnight, and at approximately 14 h a second applica-
tion of CSC was added to the medium, at 0.25% and
0.50% concentration. Four hours after the second dose
of CSC, luciferase activity was examined after luciferase
substrate (Promega) was added to cell lysates. Transfec-
tion efficiency was assessed by beta galactosidase activ-
ity, following standard protocols [39]. Cell toxicity was
evaluated by lactate dehydrogenase release using the In
Vitro Toxicology Assay Kit, Lactate Dehydrogenase
based (TOX7, Sigma), following the manufacturer’s
instructions.
Electrophoretic mobility shift assays
A549 cells were split into 10 cm cell culture plates,
allowed to grow for 24 h (to approximately 80% con-
fluency), and then treated overnight with 1 μM retinoic
acid and either 0.5% CSC or 0.5% dimethyl sulfoxide (dilu-
ent, DMSO, Sigma). Cultures were treated with a second
dose of CSC or DMSO at 14 h after the initial dose. Nu-
clear extracts were harvested at 15 min, 30 min, 60 min,
and 120 min after the second dose of CSC or DMSO
using standard protocols [40], and nuclear protein was
quantified using the Bradford Assay (Bio-Rad). Electro-
phoretic mobility shift assays (EMSA) were performedusing standard protocols [41], using 10 μg of nuclear pro-
tein with a [γ-32P] ATP radiolabeled double-stranded
DNA probe to detect a consensus sequence for the most
abundant RA response element, the RA receptor beta D5
response element [42]. Sequences for the DR5 probe were
(forward) AGGGTTCACCGAAAGTTCACTCG and
(reverse) CGAGTGAACTTTCGGTGAACCCT. The
negative control consisted of substituting an equal volume
of extraction buffer for the nuclear extract.Statistics
Data are reported as mean ± S.E.M. if normally distribu-
ted and median with interquartile ranges (25% - 75%) if
not normally distributed. Expression differences between
groups were analyzed using Student’s t-test for normally
distributed data. Data that were not normally distributed
were analyzed using non-parametric statistical tests
(Mann–Whitney). Differences were accepted as statisti-
cally significant when P< 0.05.Results
Murine model of gestational tobacco toxin exposure
We adapted a published [43-45] adult murine model of
cigarette smoke exposure to examine the effects of pre-
natal tobacco toxin exposure in juvenile mice. Total parti-
culates in this model were 310.6 mg/mm3. Cigarette
smoke-exposed pregnant adult female mice (N=8)
had significantly (P< 0.05) greater plasma levels of the
nicotine metabolite cotinine compared to tobacco-naïve
mice (N=8): the median cotinine plasma level in the
smoke-exposed mice was 30 ng/ml (interquartile range
8.9 ng/ml – 45.4 ng/ml) compared to 3.0 ng/ml (interquar-
tile range 2.6 ng/ml – 3.3 ng/ml) in the nonsmoking mice.
Similarly, median placenta cotinine levels were also signifi-
cantly (P< 0.05) increased in the smoke-exposed mice:
6.7 ng/ml (interquartile range 2.9 ng/ml – 10.1 ng/ml),
whereas no placental cotinine was detected in the tobacco-
naïve mice. The average litter size of the smoke-exposed
females was 6.5 (± 0.38) pups, which was significantly
(P=0.028) smaller than the average litter size of the non-
smoker mice: 7.8 (± 0.39) pups.
In our model, exposure to maternal smoking caused
significantly (P< 0.001) decreased weights in the off-
spring that persisted until at least postnatal day 5 (P5),
with average body weight 3.3 gm (± 0.09 gm) in the
non-exposed pups and 2.5 gm (± 0.08 gm) in the mice
with prenatal tobacco toxin exposure. Additionally, our
model showed that tobacco toxin exposure during devel-
opment significantly (P = 0.009) increased mean linear
intercept (MLI) at P14, consistent with increased average
distance between gas exchange elements in the distal
lung, in these mice compared to age-matched tobacco-























































Figure 2 Quantitative PCR analysis of RA pathway components
at postnatal day 5 (P5) comparing mice with tobacco toxin
exposure during lung development (TT, N= 9) to tobacco naïve
(NS, N= 5) mice. All results normalized to expression of 18 S.
Compared to NS mice, lung tissue samples from mice with TT had
decreased expression of retinoic acid receptors (RAR) alpha and
beta, retinoid X receptor (RXR) alpha, nuclear receptor family 2,
group F, member 2 (Nr2f2) – also known as chicken ovalbumin
upstream promoter transcription factor 2 (COUP TF 2), retinaldehyde
dehydrogenase 1 (Raldh1), and cytochrome P450 26b1 (Cyp 26b1).
Data are presented as mean± SEM. NS = tobacco naïve. Data
comparison performed using Student’s t-test for normally distributed
data and Mann–Whitney for non-normally distributed data.
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of the retinoic acid signaling pathway in a murine model
We tested the hypothesis that maternal smoking causes
abnormalities in the RA signaling pathway in the lungs
of offspring by first using quantitative PCR to compare
mRNA expression of RA signaling pathway components
in distal lung tissue RNA extracted from juvenile mice
(postnatal ages P0 – P10) with/without tobacco toxin ex-
posure during development We used 18 S ribosomal
RNA expression as an endogenous control since it is not
regulated during lung development.
This analysis showed that mice with exposure to
tobacco toxins during lung development had signifi-
cantly decreased mRNA for multiple components of the
RA signaling pathway at P5. These included RA receptor
alpha (Rara, P = 0.008), RA receptor beta (Rarb,
P = 0.008) retinoid-X receptor alpha (Rxra, P = 0.015),
retinaldehyde dehydrogenase-1 (Raldh1, P = 0.003), cyto-
chrome P450 26b1 (P< 0.001), and nuclear receptor
family 2, group F, member 2 (Nr2f2) – also known as
chicken ovalbumin upstream transcription factor 2
(COUP TF2, P = 0.023) expression on day P5 compared
to tobacco naïve mice (Figure 2). Additionally, mice with
tobacco toxin exposure also had decreased mRNA ex-
pression for retinoid X receptor gamma at P7 (Rxrg,
P = 0.021). Details of the mRNA expression analyses are
given in Supplemental Data (Additional file 1: Table S1).
Since tobacco toxin exposure during development
caused abnormal mRNA expression for several of the
elements of the RA signaling pathway, we determined if
protein expression was also affected by tobacco toxin ex-
posure. Western blot analysis was performed for retinoid
X receptor alpha (RXRalpha), RA receptor alpha (RAR-
alpha), RA receptor beta (RARbeta), and RA receptor
gamma (RARgamma) in protein extracted from distal
lung tissue from mice with and without tobacco toxin
exposure during development (N ≥ 4 each group) at time
points P3, P5, and P7. Similar to the mRNA analysis,
these studies showed significantly decreased proteinFigure 1 Increased airspace size in mice with tobacco toxin (TT) expo
mice. A. Representative section of lung tissue stained with hematoxylin an
20X) showing normal alveolar size. B. H&E stain of representative section o
enlarged airspace size, consistent with alveolarization defect. C. The mean
elements, is significantly larger in TT mice compared to NS mice. Data com
mice in group. Data are mean± SEM.expression for components of the RA signaling pathway
in mice with tobacco toxin exposure (Figure 3). How-
ever, the kinetics of the decreased protein expression dif-
fered from that of the mRNA expression. At P3,
RXRalpha (P = 0.0089), RARbeta (P = 0.0001), RAR-
gamma (P = 0.0042), and RARalpha (P = 0.0498) were all
significantly decreased in the mice with tobacco toxin
exposure. In contrast to the mRNA expression pattern,sure during lung development compared to tobacco-naïve (NS)
d eosin (H&E) from postnatal day 14 (P14) NS mouse (Magnification,
f lung tissue from P14 TT mouse (Magnification, 20X) showing
linear intercept, which reflects average distance between gas exchange

























Figure 3 Western blot analyses for retinoid X receptor alpha (RXRalpha), retinoic acid receptor alpha (RARalpha), retinoic acid receptor
beta (RARbeta), and retinoic acid receptor gamma (RARgamma) expression in distal lung tissue from mice with and without tobacco
toxin exposure during development (TT) at postnatal age P3, P5, and P7. Representative Western blots for RXRalpha (A), RARalpha (C),
RARbeta (E), and RARgamma (G). Panels B., D, F, and H: Densitometry analyses of Western blots on distal lung tissue from juvenile mice at
postnatal ages P3 with (N= 6) and without (N = 6) TT, P5 (N= 4 each with/without TT), and P7 with (N= 6) and without (N = 5) TT. Compared to
tobacco-naïve mice, TT pups expressed significantly decreased RXRalpha at each time point (B): at P3, P = 0.0089, at P5 P = 0.0138, and at P7
P = 0.0227. Decreased expression in the TT mice was also seen for RARalpha, although differences between groups were less than those for
RXRalpha, with borderline significance observed at P3 (P = 0.0498) and trends for decreased expression at P5 (P = 0.0709) at P5 and P7 (P = 0.0866)
(D). In contrast, TT mice only showed significantly decreased RARbeta at P3 (P< 0.001) (F). The expression of RARgamma was similar to that of
RARbeta, with significant decreases seen in the TT mice at P3 (P = 0.0042), with a trend toward decrease at P7 (P = 0.0728). Data comparison
performed using Student’s t-test. Abbreviations: RXR = retinoid X receptor, RAR= retinoic acid receptor.
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at P5. At P7, RXRalpha was significantly decreased
(P = 0.0227), with a trend toward decreased RARgamma
(P = 0.0728) in the tobacco toxin exposed mice. Thus,
both the mRNA and protein analysis showed that
tobacco toxin exposure during development caused sig-
nificantly decreased expression of multiple components
of the RA signaling system in the postnatal murine lung.Cigarette smoke condensate decreases RA response
element activation in vitro
RA signaling requires the formation of a RAR-RXR het-
erodimer, which then binds to a RA response element in
RA-regulated genes to modify transcription. Heterodi-
mer binding is down-regulated by Nr2f1 and Nr2f2,
which compete for the RXRs. Exposure to tobacco tox-
ins decreased expression for multiple RA pathway
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qPCR and Western blot analyses indicated that the RA
system is affected by tobacco toxin exposure, but did not
determine whether such exposures are functionally sig-
nificant. We therefore next examined whether lipid-
soluble components of cigarette smoke could possibly
affect the activation of a RA response element in an
in vitro cell culture system, using the pulmonary type II
cell-like cell line A549. We examined RA response elem-
ent activation by transfecting these cultures with a com-
mercially available luciferase reporter plasmid containing
the RA response element. This plasmid showed robust
luciferase activity following stimulation with 1 μM RA,
with minimal activity demonstrated after transfection
with the plasmid backbone (Figure 4). This luciferase ac-
tivity was significantly (P< 0.05) decreased in a dose-
dependent fashion by treating the cultures with lipid-
soluble cigarette smoke condensate (CSC, Figure 4).
Toxicity analysis by LDH release showed no significant
LDH release at the 0, 0.25, and 0.50% CSC. This analysis
did show a significant increase in LDH at 0.75% CSC,
which was a greater concentration than that which sig-
nificantly decreased luciferase activity in the A549 cells
(data not shown). Therefore, the decreased luciferase ac-
tivity was not explained by cell toxicity alone.
Decreased RA response element activation could be
caused by decreased binding of the RAR-RXR heterodimer
to the RA response element, or by decreased functioning of
the normally bound RAR-RXR heterodimer. We tested
whether decreased RAR-RXR binding contributed to the
decreased RA response activation observed in our CSC-
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Figure 4 Cigarette smoke condensate (CSC) significantly
(P< 0.05) decreases retinoic acid-stimulated (1 μM all groups)
response element (RARE) activity as detected by a luciferase
reporter plasmid in A549 cells. Luciferase activity was normalized
to that of the retinoic acid-stimulated cultures without CSC. Data
(mean± SEM) are from 4 independent experiments. Data
comparison performed using Student’s t-test.shift assays (EMSA) to determine whether CSC could de-
crease binding of nuclear extracts from A549 cells to the
well-characterized consensus binding sequence of the D5
RA response element, which is the most common of the
RA response elements [42]. EMSA confirmed that nuclear
extract from RA-treated (1 μM) A549 cells exhibited bind-
ing to the RA response element, as evidenced by a single
band in the vehicle-treated groups (lanes 2 – 5) that was
not present without addition of nuclear extract (lane 1).
Nuclear protein binding was visibly decreased following
treatment with CSC 0.50% at 30 (lane 7) and 60 (lane 8)
minutes compared with vehicle control at these same time
points (lanes 3 and 4, Figure 5A). Quantification of binding
in two different EMSAs supported a decrease in binding at
30, 60, and 120 minutes after CSC treatment compared
with vehicle control (Figure 5B). Thus, EMSA indicated
that decreased nuclear protein binding to the RA response
elements might contribute to the decreased activity of the
RA response element following CSC.
Maternal smoking decreases expression of RA-regulated
genes in vivo
Since our in vitro studies suggested that tobacco toxins
could decrease the activity of the RA signaling pathway,
we next used our murine model to determine whether
there was evidence for decreased RA signaling in mice
with tobacco toxin exposure during lung development.
RA signaling modulates several aspects of lung matur-
ation and postnatal growth including alveolarization and
surfactant apoprotein B expression. We focused these
studies on the P5 time point since that had previously
shown the greatest number of abnormalities in RA path-
way component expression in the mice with tobacco
toxin exposure. We used qPCR to compare the expres-
sion of mRNA for a panel of five genes that are regu-
lated by RA [46]: smooth muscle actin (SMA),
transforming growth factor-β (TGFβ), platelet endothe-
lial cell adhesion molecule (PECAM, CD31), vascular
endothelial growth factor (VEGF), and surfactant apo-
protein B (SPB). This analysis (Figure 6) showed that
mice exposed to tobacco toxins during lung develop-
ment had significantly decreased mRNA expression for
SMA (P = 0.016), TGF-β (P = 0.011), PECAM (P= 0.011),
VEGF (P = 0.003), and SPB (P = 0.033) at P5. Details of
the mRNA expression analyses are given in Supplemen-
tal Data (Additional file 2: Table S2). Thus, the qPCR
analyses indicate that exposure to tobacco toxins during
lung development via maternal smoking could decrease
the postnatal functioning of the RA pathway in our mur-
ine model.
Discussion
This study shows that exposure to tobacco toxins via
maternal smoking during lung development causes
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Time point    15m  30m 1h  2h        15m  30m 1h   2h
Figure 5 Cigarette smoke condensate (CSC) decreases retinoic
acid response element binding in vitro. A: Representative
electrophoretic mobility shift assay (EMSA) showing decreased
binding of nuclear extracts from A549 cells to the DR5 retinoic
acid response element after 1 μM retinoic acid and vehicle (lanes
2 – 5) or 0.50% cigarette smoke condensate (CSC, lanes 6–9)
treatment followed by second CSC dose of 0.50% 14 h after the
first, with extracts harvested at 15 – 120 min. following this
second dose. Similar results were also shown in an independent
replication. B: Relative densities of A549 cell nuclear extract/DR5
retinoic acid response element complexes (normalized to free
probe) following stimulation with 1 μM retinoic acid and either
vehicle or 0.5% CSC as outlined for panel A. Data are mean ± SEM
from two independent experiments. Abbreviations: N = negative
control lane (lane 1) with equivolume extraction buffer substituted
for the nuclear extract; numbers indicate time course in minutes,
lane numbers for samples indicated below figure, NE = nuclear
extract, CSC = cigarette smoke condensate.
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Figure 6 Real-time PCR analysis of postnatal day 5 murine lung
tissue showing significantly decreased expression of mRNA
(normalized for 18 S expression) for genes regulated by
retinoic acid that modulate alveolarization and/or postnatal
lung function in mice exposed to tobacco toxin exposure
during lung development (TT, N=5) compared to tobacco-naïve
mice (NS, N=9). Abbreviations: SMA= smooth muscle actin,
CD31= platelet endothelial cell adhesion molecule, VEGF = vascular
endothelial cell growth factor alpha, TGF-β= transforming growth
factor beta, SPB = surfactant apoprotein beta. Data are presented as
mean± SEM. Data comparison performed with Student’s t-test for
normally distributed data and Mann–Whitney for non-normally
distributed data.
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model of murine cigarette smoke exposure during preg-
nancy caused significantly increased levels of a nicotine me-
tabolite, cotinine, in both the maternal serum and placental
tissues. Of note, our analysis also detected a low-level of
cotinine in the serum, but not the placental tissues, of the
nonsmoking adult mice. The concentration of serumcotinine in these animals was very low, near the limits of
detection of our assay, and corresponded to similar findings
reported in other rodent models [47,48]. The source of
cotinine in the nonsmoking mice is not clear, however, it is
possible that it may be a dietary source and/or vitamin sup-
plement – niacin has been reported to cross-react with
cotinine assays, and low levels of nicotine have been
demonstrated in some none-tobacco plants [49,50]. Similar
to what other investigators have reported [51], mice with
tobacco toxin exposure during development had decreased
weights compared to tobacco-naïve pups. In our model, the
differences in weights were detected through postnatal day
5 (P5).
Regarding the histological changes in the juvenile mice
with developmental tobacco toxin exposure, our model
caused a significant increase in the mean linear intercept,
which is an estimate of the average distance between gas
exchange elements, at P14. This is consistent with defect-
ive alveolarization in the mice with tobacco toxin expos-
ure during lung development. While commonly used to
compare distal lung architecture [43,45,52-64], the mean
linear intercept does not provide an accurate assessment
of the irregularly shaped alveolus [34]. Additionally, it is
not as sensitive as other morphometric approaches, espe-
cially if the changes in tissue architecture are not uni-
formly distributed throughout the lung parenchyma
[34,65]. Thus, our analysis may have underestimated the
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architecture. Of note, cigarette smoke exposure in adult
mice frequently requires several months to establish
emphysematous-like changes [43-45,62,63]. Our finding
of defective alveolarization following tobacco toxin expos-
ure during gestation and neonatal lung development, simi-
lar to that reported by other investigators [57,66], suggests
that the immature lung may have heightened susceptibility
to the effects of tobacco toxins.
The histological abnormalities were associated with
decreased mRNA and protein expression of several RA
signaling pathway elements in distal lung tissue from
mice with tobacco toxin exposure during lung develop-
ment. This analysis examined time points which encom-
passed the start of rapid alveolarization in the mouse, of
which retinoids are critical mediators [18,21,22,67,68].
Unexpectedly, these abnormalities were not greatest im-
mediately after birth, but instead were greatest between
P3 to P5, and diminished thereafter. Thus, the effects of
maternal smoking persisted in the juvenile mice for sev-
eral days after birth. The significance of the P5 time
point is that this is immediately before the onset of rapid
alveolarization in the mouse [69]. Therefore, abnormal-
ities at this time point might have a disproportionately
greater impact on alveolarization, such as those shown
in our histological analyses. Our data suggest that the
effects of developmental exposure to tobacco toxins are
greatest at this important postnatal period of lung mat-
uration. The onset of alveolarization is characterized by
down-regulation of Rara, Rarb, and Rarg isoforms in the
lung [70,71]. However, the roles of the retinoids in alveo-
larization are complex – absence of Rara and/or Rarg
causes defective alveolarization [22,72]. These studies in-
dicate that, normal alveolarization requires precise regu-
lation of the kinetics and abundance of retinoids
[21,71,73]. Our data suggest that tobacco toxin exposure
during development disrupts this highly regulated process.
We tested whether the decrease in RA pathway com-
ponents could possibly be functionally significant by
examining an in vitro cell culture model. Our analysis of
the expression of RA pathway components showed that
a negative regulator of RAR signaling, Nr2f2, was
decreased in the mice with tobacco toxin exposure. The
decrease in a negative regulator would be expected to
increase RA signaling. However, the decreased expres-
sion of the other components of the RA pathway would
tend to decrease RA signaling. Thus, our RNA expres-
sion findings did not clearly indicate whether RA signal-
ing would be affected by cigarette smoke exposure. We
therefore determined whether components of cigarette
smoke could possibly affect activation of a RA response
element in an in vitro cell culture model. Treatment of
the type II-like cell line, A549, with cigarette smoke con-
densate (CSC) decreased activation of a RA responseelement in a luciferase reporter plasmid, and EMSA
demonstrated that CSC decreased binding of nuclear
extracts prepared from A549 cells to the most common
RA response element, the DR5. Such decreased binding
and RA response element activation would tend to re-
duce RA-regulated gene transcription. Therefore, our
cell culture data suggested that it would be feasible for
tobacco toxin exposure to affect the functioning of the
RA signaling pathway in vivo.
Since our in vitro model suggested that components
of cigarette smoke might decrease RA signaling in lung
cells, we examined our in vivo model of murine devel-
opmental tobacco toxin exposure for similar evidence of
decreased RA pathway function by examining mRNA
expression of RA-regulated genes in lung tissue from
mice with developmental tobacco toxin exposure. This
analysis showed that prenatal cigarette smoke exposure
decreased mRNA for SMA [74,75], CD31 [76], TGF-β
[77,78], VEGF [79], and SPB [80,81] – all of which
modulate postnatal alveolarization and/or lung func-
tion. Additionally, RA modulates the expression of all of
these genes [46]. The effects of RA on these genes can
vary with the specific model studied. RA modulation of
TGF-β provides a good example of the context-
dependent effects of RA, since RA has been shown to
both decrease [82,83] and increase [84-86] TGF-β ex-
pression. RA can increase transcription either by dir-
ectly activating RA response elements in the upstream
promoter region, as observed with SPB [23], and/or by
modulating the activity of transcription factors such as
hypoxia-inducible factor-1α [87]or Sp1 [88,89], as is the
case with VEGF, SMA [90], and PECAM [91,92]. The
two mechanisms are not mutually exclusive. For ex-
ample, RA-modulation of SPB includes activation of a
promoter RA response element [23] and activation of
transcription factors TTF-1 [93,94], signal transducers
and activators of transcription-3 (STAT3), and Janus
family tyrosine kinase-1 (JAK1) [95]. Additionally, the
effects of RA can be amplified by RA-mediated increase
in growth factor receptors, which occurs with VEGF
[96] and TGF-β. Thus, our in vitro and in vivo data sup-
port the hypothesis that components of cigarette smoke
can decrease the activity of the RA signaling pathway in
the immature lung.
The retinoids are critical mediators of lung develop-
ment and maturation [68,70,97-103], including alveolari-
zation [20,22,72]. However, this signaling pathway has
not been extensively studied in relation to cigarette
smoking. Animal models have shown decreased serum
vitamin A levels following cigarette smoke exposure in
adult rats. The serum vitamin A levels were inversely
correlated with the amount of emphysematous changes
in lung tissue [26]. Moreover, a recent study in adult
C57Bl/6 mice showed that vitamin A deficiency
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induced lung damage in comparison to cigarette smoke
exposure in vitamin A-replete mice [104]. In humans,
several studies have reported that cigarette smokers have
decreased serum beta carotene [27,28]; one large study
has also shown decreased serum retinol levels in current
smokers compared to former smokers [28]. Cigarette
smoking increases methylation of the promoter of the
gene encoding RAR-beta, thereby decreasing expression
of this receptor [105-107]. Additionally, squamous meta-
plasia is observed in both vitamin A deficiency and smo-
kers [103], and a clinical trial of supplementing 13-cis
RA showed improved lung epithelial histology [108].
However, clinical trials of supplementing beta carotene
in active smokers showed a trend toward increased lung
cancer in patients receiving beta carotene. Subsequent
analysis suggests that the mechanism of this increase
could be due to down-regulation of RA signaling caused
by excess beta carotene [109,110].
Our data extend the findings of other investigators
studying the effects of maternal smoking in animal mod-
els. Both maternal nicotine treatment and cigarette
smoke exposure disrupt alveolarization in rats, guinea
pigs, mice, and rhesus monkeys [66,111-115]. Of note, a
recent report by Singh and colleagues demonstrated that
maternal smoking decreased cAMP in the lung tissue of
the offspring [66]. Although retinoids were not specific-
ally examined in that study, cAMP can modulate the ac-
tivity of Rara through protein kinase A sites in the Rara
promoter [116-118].
Our murine model has several limitations. First, the
control mice were exposed to filtered air only, and not
put into unused smoking chambers (sham-exposed). Fil-
tered air as the control exposure has been used by other
investigators examining cigarette smoke exposure in
adult mice, and has been found to be equivalent to sham
exposures [44,45,62]. However, we cannot rule out a
possible contribution from the enclosure in the smoking
chamber in our tobacco toxin-exposed mice. Addition-
ally, the maternal cigarette exposure was continued fol-
lowing parturition. This was necessary because our
preliminary experiments established that maternal be-
havior was very poor if the cigarette exposure was
abruptly discontinued following delivery. Thus, our
model did not isolate the tobacco toxin exposure to ges-
tation. Since lung development in the mouse continues
for at least two weeks after birth [69,119], our findings
remain informative regarding the effects of tobacco toxin
exposure in the developing lung despite this limitation.
Another limitation is that our in vitro cell culture
experiments provide supportive, but not conclusive, evi-
dence of decreased RA signaling following tobacco toxin
exposure during lung development. Definitive experi-
ments to prove that tobacco toxin exposure decreasesRA signaling in the immature lung would require a
detailed analysis of in vivo signaling pathway activity,
and are beyond the scope of this report.
Conclusions
Our data show that exposure to tobacco toxins during
development decreases the expression of RA pathway
elements in the immature lung, which indicates that this
important signaling pathway is vulnerable to the effects
of maternal smoking during pregnancy. The decreases
were most pronounced immediately before the onset of
rapid alveolarization, at post-natal days 3–5. In vitro
experiments using a luciferase reporter plasmid showed
that CSC decreased activation of the RA response elem-
ent. Additionally, tobacco toxin exposure during devel-
opment decreased the expression of RA-regulated genes,
suggestive of decreased RA pathway functioning in the
smoke-exposed mice. We therefore propose that
decreased RA pathway activity may be a mechanism of
lung injury caused by prenatal tobacco toxin exposure,
and may represent a therapeutic target for pediatric lung
disease that arises from maternal smoke exposure.
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